| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CARCIN/BGQ209 |
| P953 | full work available at URL | https://academic.oup.com/carcin/article-pdf/32/1/2/7518435/bgq209.pdf |
| http://carcin.oxfordjournals.org/cgi/content/abstract/32/1/2 | ||
| http://academic.oup.com/carcin/article-pdf/32/1/2/7518435/bgq209.pdf | ||
| P3181 | OpenCitations bibliographic resource ID | 2426652 |
| P698 | PubMed publication ID | 20952513 |
| P5875 | ResearchGate publication ID | 47449791 |
| P2093 | author name string | Bo Zhang | |
| Qian Zhao | |||
| Guo-Qiang Chen | |||
| Meng Guo | |||
| Ming He | |||
| Mei-Fang Li | |||
| Ci-Xiang Zhou | |||
| Jian-Rong He | |||
| Xiao-Xiao Liu | |||
| P2860 | cites work | Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity | Q40120851 |
| A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells | Q40228726 | ||
| Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth | Q43262197 | ||
| Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma | Q46123225 | ||
| MicroRNAs as oncogenes and tumor suppressors | Q81406722 | ||
| Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis | Q24321673 | ||
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| microRNAs exhibit high frequency genomic alterations in human cancer | Q24546369 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 | ||
| MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer | Q24651422 | ||
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells | Q24672969 | ||
| Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc | Q24676725 | ||
| The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells | Q24680814 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| let-7 regulates self renewal and tumorigenicity of breast cancer cells | Q28261263 | ||
| Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor | Q28264817 | ||
| Genome regulation by polycomb and trithorax proteins | Q28289984 | ||
| MYC stimulates EZH2 expression by repression of its negative regulator miR-26a | Q28291303 | ||
| X chromosomal abnormalities in basal-like human breast cancer | Q28296876 | ||
| Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma | Q28304953 | ||
| Zcchc11-dependent uridylation of microRNA directs cytokine expression | Q28511274 | ||
| Modulation of microRNA processing by p53 | Q29620776 | ||
| Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
| EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer | Q34268216 | ||
| Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. | Q34628232 | ||
| Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. | Q37330716 | ||
| The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells | Q38289292 | ||
| Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival | Q38426352 | ||
| Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells | Q39883966 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| apoptotic process | Q14599311 | ||
| carcinogenesis | Q1637543 | ||
| neoplastic gene expression regulation | Q66660300 | ||
| P304 | page(s) | 2-9 | |
| P577 | publication date | 2010-10-15 | |
| 2011-01-01 | |||
| P1433 | published in | Carcinogenesis | Q326022 |
| P1476 | title | Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer | |
| P478 | volume | 32 |
| Q37022397 | AEG-1/MTDH-activated autophagy enhances human malignant glioma susceptibility to TGF-β1-triggered epithelial-mesenchymal transition |
| Q28658809 | AEG-1/MTDH/LYRIC, the beginning: initial cloning, structure, expression profile, and regulation of expression |
| Q27014932 | AEG-1/MTDH/LYRIC: clinical significance |
| Q89777029 | An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth |
| Q28072414 | ApoptomiRs of Breast Cancer: Basics to Clinics |
| Q35024139 | Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice |
| Q35651246 | Cellular microRNA miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by activating innate antiviral immunity |
| Q37013250 | Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer |
| Q92617953 | Diagnostic value of a microRNA signature panel in exosomes for patients with hepatocellular carcinoma |
| Q34229869 | Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration |
| Q38789206 | Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2 |
| Q36088836 | Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma |
| Q37687781 | Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma |
| Q35222823 | EZH2 as a potential target in cancer therapy |
| Q57149171 | EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3 |
| Q38019814 | EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis |
| Q47931449 | Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis |
| Q55241876 | Enhancer of zeste homolog 2 blockade by RNA interference is implicated with inhibited proliferation, invasion and promoted apoptosis in endometrial carcinoma. |
| Q35673753 | Epigenetic Regulation of miRNAs and Breast Cancer Stem Cells |
| Q51750442 | Expressed microRNA associated with high rate of egg production in chicken ovarian follicles. |
| Q34358599 | Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing |
| Q53078040 | Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. |
| Q38972834 | HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes |
| Q36320924 | High-throughput sequencing of pituitary and hypothalamic microRNA transcriptome associated with high rate of egg production |
| Q35216079 | Histone modifiers in cancer: friends or foes? |
| Q41740532 | Host miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by upregulating type I interferons |
| Q45020503 | Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients |
| Q33739866 | Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2. |
| Q34738566 | Identification of miRNAs associated with sexual maturity in chicken ovary by Illumina small RNA deep sequencing |
| Q49236880 | Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A. |
| Q47912856 | Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma. |
| Q33952948 | Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance |
| Q64071558 | LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis |
| Q38736898 | Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. |
| Q46914425 | MIROR: a method for cell-type specific microRNA occupancy rate prediction |
| Q36694223 | MTDH genetic variants in colorectal cancer patients. |
| Q39582286 | Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. |
| Q34110914 | Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells |
| Q33788005 | Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition |
| Q38897001 | MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer |
| Q36870550 | MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1. |
| Q37744911 | MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy |
| Q36757035 | MiR-26a Rescues Bone Regeneration Deficiency of Mesenchymal Stem Cells Derived From Osteoporotic Mice |
| Q38750019 | MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. |
| Q37046835 | MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. |
| Q34764211 | MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1 |
| Q90405854 | MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19 |
| Q37505913 | MiR-26a promotes ovarian cancer proliferation and tumorigenesis |
| Q50133239 | MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells. |
| Q36738807 | MiR-630 suppresses breast cancer progression by targeting metadherin |
| Q41997354 | MiRNAs in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity |
| Q42149272 | MicroRNA 26a prolongs skin allograft survival and promotes regulatory T cell expansion in mice |
| Q93108431 | MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer |
| Q34026900 | MicroRNA and mRNA expression profiling in rat acute respiratory distress syndrome |
| Q35553338 | MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype |
| Q85648663 | MicroRNA-26a Promotes Regulatory T cells and Suppresses Autoimmune Diabetes in Mice |
| Q49790324 | MicroRNA-26a and Tumor |
| Q39985065 | MicroRNA-26a induces osteosarcoma cell growth and metastasis via the Wnt/β-catenin pathway |
| Q35032496 | MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma |
| Q55042929 | MicroRNA-26a inhibits hyperplastic scar formation by targeting Smad2. |
| Q28280193 | MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD) |
| Q39123359 | MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin |
| Q33807718 | MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells |
| Q47616223 | MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway |
| Q36433424 | MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. |
| Q46255425 | MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway |
| Q42290877 | MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia |
| Q40625630 | MicroRNA-26a-interleukin (IL)-6-IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model |
| Q38714023 | MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines |
| Q35755282 | MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway |
| Q92645467 | MicroRNA-26b inhibits the immune response to Mycobacterium tuberculosis (M.tb) infection in THP-1 cells via targeting TGFβ-activated kinase-1 (TAK1), a promoter of the NF-κB pathway |
| Q28236122 | MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11 |
| Q37609283 | MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. |
| Q39447513 | MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo |
| Q50059724 | MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1. |
| Q64249164 | MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis |
| Q36847079 | MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction |
| Q38045799 | Non-coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome. |
| Q37091954 | Overexpression of miR-26b-5p regulates the cell cycle by targeting CCND2 in GC-2 cells under exposure to extremely low frequency electromagnetic fields |
| Q64889642 | Perturbation of epigenetic processes by doxorubicin in the mouse testis. |
| Q47127377 | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. |
| Q36504138 | Polymorphisms in pre-miRNA genes and cooking oil fume exposure as well as their interaction on the risk of lung cancer in a Chinese nonsmoking female population |
| Q34043370 | Regulation and Role of EZH2 in Cancer |
| Q38765720 | Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer. |
| Q37936584 | Regulation of microRNA expression and function by nuclear receptor signaling |
| Q38785857 | Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma |
| Q90441652 | Regulatory role of miRNA-26a in neonatal sepsis |
| Q38728098 | Sialyltransferase ST3GAL6 mediates the effect of microRNA-26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathway |
| Q98386355 | Small RNA profiles of HTLV-1 asymptomatic carriers with monoclonal and polyclonal rearrangement of the T-cell antigen receptor γ-chain using massively parallel sequencing: A pilot study |
| Q42289696 | Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR. |
| Q90469311 | Targeting of CD38 by the tumor suppressor miR-26a serves as a novel potential therapeutic agent in multiple myeloma |
| Q37210093 | The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer |
| Q34512485 | The MTDH (-470G>A) polymorphism is associated with ovarian cancer susceptibility |
| Q40283637 | The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis |
| Q35014682 | The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival |
| Q42063012 | The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. |
| Q47318149 | The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. |
| Q24629056 | The role of miR-26 in tumors and normal tissues (Review) |
| Q38796729 | The role of microRNA-26a in human cancer progression and clinical application |
| Q34507168 | The role of the 3'UTR region in the regulation of the ACVR1/Alk-2 gene expression |
| Q35022495 | The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axis |
| Q47161423 | Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expression |
| Q34181700 | Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells |
| Q34590225 | Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis |
| Q39507167 | Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). |
| Q95840792 | Vascular Signaling in Allogenic Solid Organ Transplantation - The Role of Endothelial Cells |
| Q34786575 | miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma |
| Q61449913 | miR-26 Induces Apoptosis and Inhibits Autophagy in Non-small Cell Lung Cancer Cells by Suppressing TGF-β1-JNK Signaling Pathway |
| Q37564535 | miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13. |
| Q39135735 | miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. |
| Q36841322 | miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression |
| Q92761624 | miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2 |
| Q38799066 | miR-26a regulates mouse hepatocyte proliferation via directly targeting the 3' untranslated region of CCND2 and CCNE2. |
| Q38003705 | miRNAs in breast cancer: ready for real time? |
| Q37661923 | miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions |
| Q92864830 | microRNA and Other Small RNA Sequence Profiling across Six Tissues of Chinese Forest Musk Deer (Moschus berezovskii) |
| Q55054170 | microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma. |
| Q35684366 | microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma. |
| Q38336073 | microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer |
Search more.